A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease

NCT02730091 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Letrozole
DRUG: Anastrozole
DRUG: Vinorelbine

Sponsor

Centre Hospitalier Universitaire de Besancon

Collaborators

[object Object]